PhillyPharma Archive: April, 2013

Boston lock-down keeps pharmaceutical employees home or on site

Comment icon 0 Comments
Pfizer, Merck, GlaxoSmithKline and Johnson & Johnson are among the pharmaceutical companies with Boston-area operations, so they had employees... Read more

New drugs move stocks, whatever might come next

Comment icon 0 Comments
Months ago at an investor day, a Wall Street analyst in the audience during the question-and-answer portion of the event, told Merck &... Read more

FDA panel splits on Endo Health Solutions' testosterone drug Aveed

Comment icon 0 Comments
A Food and Drug Administration panel was split Thursday on whether Malvern-based Endo Health Solutions' testosterone drug Aveed was safe enough... Read more

FDA won't approve original generic versions of painkiller OxyContin, which are easier to abuse

Comment icon 0 Comments
The Food and Drug Administration late Tuesday halted plans of generic drug companies hoping to sell their versions of the opioid painkiller... Read more

Fort Washington plant still on hold, but J&J says more Tylenol and Motrin on shelves

Comment icon 0 Comments
Though its Fort Washington plant is still being under repair and overall profits fell 10 percent in the first quarter of 2013, Johnson &... Read more

Supreme Court juggles molecular structure, cookie recipes and baseball bats in gene therapy case

Comment icon 0 Comments
WASHINGTON - Molecules and chocolate chip cookies, baseball bats and Amazonian tree sap were all part of a spirited Supreme Court discussion... Read more

Supreme Court denies Glaxo appeal, allowing Humana to sue the drugmaker

Comment icon 0 Comments
The U.S. Supreme Court Monday denied a request by drugmaker GlaxoSmithKline to hear its appeal of a decision by U.S. Court of Appeals for the... Read more

Myriad Genetics will tell Supreme Court its patents are worthy because their did more than slice and dice genes

Comment icon 0 Comments
Myriad Genetics will defend its gene patents Monday in the U.S. Supreme Court, and part of its public relations defense is that by isolating... Read more